搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
Barchart on MSN
9 小时
Can This Growth Stock Deliver 135% Upside in 2025?
Celldex Therapeutics (CLDX) is a clinical-stage biotechnology company that focuses on developing targeted therapies for rare ...
12 小时
LEO Pharma Launches Talk to the Hand Campaign to Raise Awareness of the Impact of Chronic ...
LEO Pharma Inc., a global leader in medical dermatology, has launched Talk to the Hand, a disease awareness campaign for healthcare providers that highlights the risk factors, symptoms, and physical ...
3 天
The dangers lurking in your Halloween treats – from hives to heart palpitations and ...
YOUR favourite spooky treat might be harbouring an unwanted trick, an expert has warned. Some ingredients lurking in your ...
4 天
Jasper Therapeutics Reports Positive Data from SPOTLIGHT Study of Briquilimab in Chronic ...
No serious adverse events; no grade 3 or higher adverse events reported Initial data from BEACON study expected week of ...
5 天
Why that constant itch could be a sign of kidney disease, poor liver function, thyroid ...
For more than 50 years Martyn Pring's (right) life was dominated by an 'uncontrollable' urge to itch - and nothing doctors ...
6 天
Celldex’s Barzolvolimab Outperforms Competitor in Chronic Inducible Urticaria Market ...
Leerink Partners analyst Thomas Smith maintained a Buy rating on Celldex (CLDX – Research Report) on October 14 and set a price target of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈